Compound information
- Natural Products
- ZC1004309
- Molecular Formula
- C16H20N6O2S
- Molecular Weight
- 360.13684488 g/mol
- Structure
-
- IUPAC Name
- N4,N4-dimethyl-N1-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1,4-dicarboxamide
- InChI
- InChI=1S/C16H20N6O2S/c1-20(2)16(24)22-10-8-21(9-11-22)15(23)18-14-17-13(19-25-14)12-6-4-3-5-7-12/h3-7H,8-11H2,1-2H3,(H,17,18,19,23)
- InChI Key
- URPJKQBIASSJLV-UHFFFAOYSA-N
- SMILES
- CN(C)C(=O)N1CCN(C(=O)Nc2nc(-c3ccccc3)ns2)CC1
- Source
- ZINC000063844579
Warheads
- Urea carbonyl
-
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 81.67 Å2 | LogP | 2.148 |
LogS | -2.611 | LogD | 2.28 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.011 | Pgp substrate | 0.995 |
HIA | 0.332 | F20 % | 0.054 |
F30 % | 0.053 | Caco-2 | -4.488 |
MDCK | -5.48 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.835 | PPB | 93.225 |
VD | 0.694 | Fu | 1.217 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.316 | CYP1A2 substrate | 0.623 |
CYP2A6 substrate | 0.362 | CYP2B6 substrate | 0.644 |
CYP2C19 inhibitor | 0.449 | CYP2C19 substrate | 0.7 |
CYP2C8 substrate | 0.622 | CYP2C9 inhibitor | 0.208 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.026 |
CYP2D6 substrate | 0.975 | CYP2E1 substrate | 0.716 |
CYP3A4 inhibitor | 0.025 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.692 | CL | 5.409 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.013 | Hepatotoxicity | 0.567 |
Mutagenicity | 0.01 | Rat Oral Acute Toxicity | 0.529 |
FDAMDD | 0.174 | Skin Sensitization | 0.654 |
Carcinogenicity | 0.814 | Eye Corrosion | 0.003 |
Eye Irritation | 0.009 | Respiratory Toxicity | 0.574 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.134 | IGC50 | 1.945 |
LC50FM | 0.236 | LC50DM | -3.954 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.543 | NR-AR-LBD | 0.221 |
NR-AhR | 0.96 | NR-Aromatase | 0.028 |
NR-ER | 0.595 | NR-ER-LBD | 0.303 |
NR-PPAR-gamma | 0.403 | SR-ARE | 0.791 |
SR-ATAD5 | 0.765 | SR-HSE | 0.126 |
SR-MMP | 0.147 | SR-p53 | 0.072 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.